Compare Citius Pharmaceuticals Inc (CTXR) vs Enphase Energy Inc (ENPH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs Enphase Energy Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Enphase Energy Inc trades at $42.6 (market cap $5.59B). The key difference: Enphase Energy Inc is far larger — about 279.4× Citius Pharmaceuticals Inc's market cap, and Enphase Energy Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | ENPH | |
|---|---|---|
Market Cap | $20.01M | $5.59B |
Sector | Health | Technology |
52-Week High | $1.82 | $72.33 |
52-Week Low | $0.48 | $26.12 |
Enterprise Value | $16.23M | $5.23B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →
